Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | +1.57% | -4.09% | +30.30% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
Financials (USD)
Sales 2024 * | 37.9M | Sales 2025 * | 35.29M | Capitalization | 227M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -29M | EV / Sales 2024 * | 6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.44 x |
P/E ratio 2024 * |
-19.5
x | P/E ratio 2025 * |
-9.41
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | +1.60% | ||
1 week | -5.58% | ||
Current month | -1.55% | ||
1 month | -4.15% | ||
3 months | +43.50% | ||
6 months | +173.12% | ||
Current year | +28.28% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 65 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.58 | +1.57% | 286 889 |
24-03-27 | 2.54 | +1.60% | 312,741 |
24-03-26 | 2.5 | -1.19% | 215,475 |
24-03-25 | 2.53 | -4.17% | 294,933 |
24-03-22 | 2.64 | -1.12% | 232,606 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.28% | 227M | |
+9.16% | 45.97B | |
+53.18% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |